Gene Logic Licenses Parts of GeneExpress to Morphochem | GenomeWeb

NEW YORK, Feb. 19 - Gene Logic on Tuesday said that Morphochem has subscribed to parts of its GeneExpress technology.

Morphochem researchers will use the GeneExpress oncology DataSuite and the  Reports tool, which was designed to offer a body-wide assessment of targeted genes. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.